Lonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range
The provision of high-quality cells that are known to grow successfully in 3D culture will help fast track organ-on-a-chip (OOC) adoption and customer research